COGNITIVE RESEARCH CORPORATION
LIVE

Serial Number

97933509

Owner

Cognitive Research Corporation

Attorney

WILLIAM S. FULTZ

Filing Date

May 12, 2023

Add to watchlist:

No watchlists yet
View on USPTO

COGNITIVE RESEARCH CORPORATION Trademark

Serial Number: 97933509

COGNITIVE RESEARCH CORPORATION is a trademark filed by Cognitive Research Corporation on May 12, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Cognitive Research Corporation (3 trademarks)

200 Central Avenue Suite 1230
St. Petersburg, FL 33701

Entity Type: 03

Trademark Details

Filing Date

May 12, 2023

Registration Date

Not Registered

Published for Opposition

June 24, 2025

Goods & Services

Diagnostic apparatus for research laboratory use for testing cognitive function; Vehicle driving and control simulators for scientific and medical research purposes

Design and development of clinical trials for others; Consulting services for others in the field of design, planning, and implementation project management of scientific research and clinical trials; Scientific research consulting; Consulting services in the field of pharmaceutical research and development; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of clinical trials; Scientific and technological services, namely, statistical and biostatistical research and analysis in the field of clinical trials; Technical medical writing for others; Providing medical and scientific research information; Clinical trial data management services, namely, compiling data for research purposes in the field of medical science and medical consultancy related to clinical trials; Consulting services for others in the field of implementation project management of clinical trials for others

Business consulting and management in the field of medical and scientific research and clinical trials and studies; Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs and medical devices with governmental regulatory bodies; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, pharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting and management in the field of clinical trials, namely, providing information management services; Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Compilation and provision of statistical and biostatistical information for business or commercial purposes; Marketing services for the medical devices and clinical research of medical, pharmaceutical and biotechnology companies; Marketing services in the field of clinical trials and of scientific and medical research and development

Regulatory compliance consulting and auditing in the field of clinical trials

Educational services, namely, providing continuing education courses in the field of scientific and medical research and drug development; Educational services, namely, providing educational speakers in the field of scientific and medical research and drug development

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 5, 2026 NOAM
TTAB RELEASE CASE TO TRADEMARKS
Mar 24, 2026 TMBN
OPPOSITION TERMINATED NO. 999999
Mar 24, 2026 OP.T
OPPOSITION DISMISSED NO. 999999
Mar 24, 2026 OP.D
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Aug 23, 2025 ETOP
OPPOSITION INSTITUTED NO. 999999
Aug 22, 2025 OP.I
EXTENSION OF TIME TO OPPOSE RECEIVED
Jul 15, 2025 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 24, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 24, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 18, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 21, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 21, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 21, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 21, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 19, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 19, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 19, 2025 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
May 14, 2025 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
May 13, 2025 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 22, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 22, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 21, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 21, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jan 21, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jan 21, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 21, 2024 GNRN
NON-FINAL ACTION E-MAILED
Oct 21, 2024 GNRT
NON-FINAL ACTION WRITTEN
Oct 21, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 30, 2024 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 18, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 18, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 18, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 7, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 7, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 7, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 20, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 20, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 20, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 8, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 8, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 8, 2024 GNRN
NON-FINAL ACTION E-MAILED
Feb 8, 2024 GNRT
NON-FINAL ACTION WRITTEN
Feb 8, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 6, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 13, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 12, 2023 NWOS
NEW APPLICATION ENTERED
May 16, 2023 NWAP